文献速递急性肾损伤水电解质与酸碱

维生素K拮抗剂治疗患者急性肾损伤期间过度抗凝风险

Risk of overanticoagulation during acute kidney injury in patients treated with vitamin K antagonists.
PubMed 文献 · Nephrol Dial Transplant · 2022-01-01

该回顾性研究从三级肾脏病中心收集100例接受VKA治疗期间发生AKI的患者,比较肾衰竭时与肾功能稳定时的INR。女性、低BMI和糖尿病患者易出现过度抗凝。

要点

  • AKI期间VKA抗凝效应显著增强,中位INR从2.24升至3.17。
  • 女性、低BMI和糖尿病患者在AKI期间易发生过度抗凝。

核心结论

  • AKI可导致VKA治疗患者INR升高和过度抗凝,增加出血风险,在高危AKI患者中应予以考虑。

研究设计与样本

  • 回顾性研究,从三级肾脏病中心收集100例接受VKA治疗期间发生AKI的患者,比较AKI时与肾功能稳定参考时间点的INR。

主要发现

  • AKI时平均INR高于参考时间点(中位3.17,范围1.10-13.0 vs 中位2.24,范围1.07-5.17;P<0.0001)。
  • 24例患者在AKI期间发生出血并发症,55例需减少VKA剂量。
  • 女性、低体重指数和糖尿病患者在AKI期间易出现过度抗凝。
  • AKI病因包括容量不足(n=43)、感染性肾衰竭(n=22)、失代偿性心力衰竭(n=18)和中毒性肾损害(n=11)。

临床怎么用

  • 对接受VKA治疗且发生AKI的患者,应加强INR监测并警惕过度抗凝和出血风险。
  • 对女性、低BMI和糖尿病等易感患者,AKI期间应更密切监测INR并及时调整VKA剂量。

局限性

  • 回顾性研究设计,样本来自单中心,可能存在选择偏倚和信息偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Vitamin K antagonists (VKAs) are still in use for oral anticoagulation, but not all indications allow their replacement by direct oral anticoagulants. Although formal dose reduction is not required in patients with impaired kidney function, case reports indicate that acute kidney injury (AKI) might be associated with derailment of VKA therapy. METHODS: The study retrospectively collected patients from a tertiary nephrology care centre who experienced AKI while being treated with VKA. In these individuals, the international normalized ratio (INR) as a measure of anticoagulant effect during renal failure was compared with a reference time point with stable kidney function. RESULTS: A total of 100 patients with AKI and ongoing VKA therapy met the inclusion criteria. The majority (76%) of patients had AKI with CKD. Volume depletion (n = 43), septic renal failure (n = 22), decompensated heart failure (n = 18) and toxic renal damage (n = 11) were the most important causes of AKI. The average INR values at the time of AKI were higher than at the reference time point [median 3.17 (range 1.10-13.0) versus 2.24 (1.07-5.17); P < 0.0001]. Fifty-four patients had INR values above the recommended therapeutic range for their indication at the time point of AKI. Bleeding complications occurred in 24 patients during AKI and the VKA dose had to be reduced in 55. Women, patients with low body mass index and patients with diabetes were predisposed to overanticoagulation during AKI. CONCLUSIONS: The effect of AKI on anticoagulation by VKA has not been systematically described. This risk should be considered in patients at high risk for AKI.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Süfling L, Greinert D, Girndt M, et al. Risk of overanticoagulation during acute kidney injury in patients treated with vitamin K antagonists. Nephrol Dial Transplant. 2022. PMID: 33459792. doi:10.1093/ndt/gfab008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。